The Centre has issued guidelines on COVID-19 vaccine, comprising how the whole inoculation drive would be carried out. The guidelines include vaccinating 100-200 people in each session per day, monitoring them for 30 minutes after administering the shots for any adverse event and allowing only one beneficiary at a time.
The COVID Vaccine Intelligence Network (Co-WIN) system–a digitalised platform–will be used to track enlisted beneficiaries for the vaccination and anti-coronavirus vaccine, as per the guidelines issued recently to states quoted by a PTI report.
At the vaccination site, only pre-registered beneficiaries will be vaccinated in accordance with the prioritisation, and there will be no provision for on the-spot registrations, the report said. The states have been asked, as far as possible, to allocate the vaccine from one manufacturer to a district to avoid mixing of different COVID-19 vaccines in the field.
As per the ‘COVID-19 Vaccine Operational Guidelines’, all measures should be taken to avoid exposing the vaccine carrier, vaccine vials or ice packs to direct sunlight, the document stated.
“There may not be vaccine vial monitors (VVM) and Date of Expiry on the label of COVID-19 vaccine, this should not discourage vaccinators from using the vaccine. At the end of the session, the vaccine carrier with all ice packs and unopened vaccine vials should be sent back to the distributing cold chain point,” the guidelines said.
States have been asked to implement an integrated 360-degree comprehensive advocacy communication and social mobilisation strategy to address the challenges surrounding vaccine roll out progress and benefits.
The vaccination team will consist of five members, it said.
Each session should be planned for 100 beneficiaries per day. If the session site has adequate logistics and space available for waiting room and observation room along with arrangement for crowd management, one more vaccinator officer can be added to create a session for 200 beneficiaries, the guidelines stated.
The COVID-19 vaccine will be offered first to healthcare workers, front line workers and to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities based on the evolving pandemic situation, and finally to the remaining population based on the disease epidemiology and vaccine availability. Under phase one of the vaccination, it is planned to vaccinate nearly 30 crore population.